Literature DB >> 12594944

At the innate frontiers between mother and fetus: linking abortion with complement activation.

Stéphane M Caucheteux1, Colette Kanellopoulos-Langevin, David M Ojcius.   

Abstract

The intricate mechanisms regulating fetomaternal interactions are still largely uncharacterized. Recent papers have revealed a major role for the innate immune system during abortion. Different experimental conditions-deletion of a complement regulator, injection of anti-phospholipid antibodies into mothers, or allo-recognition of fetuses in the presence of an IDO inhibitor-all lead to complement activation, inflammation, and fetal loss. These observations also raise new questions on the relationship between the adaptive and innate systems during pregnancy.

Entities:  

Mesh:

Year:  2003        PMID: 12594944     DOI: 10.1016/s1074-7613(03)00028-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  22 in total

Review 1.  A noninflammatory pathway for pregnancy loss: innate immune activation?

Authors:  Jane E Salmon
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

2.  CD1d-restricted NKT cells modulate placental and uterine leukocyte populations during chlamydial infection in mice.

Authors:  Mohamed Habbeddine; Philippe Verbeke; Christiane Delarbre; René Moutier; Stéphane Prieto; David M Ojcius; Colette Kanellopoulos-Langevin
Journal:  Microbes Infect       Date:  2013-08-31       Impact factor: 2.700

3.  Maternal and fetal alternative complement pathway activation in early severe preeclampsia.

Authors:  M Camille Hoffman; Kristen K Rumer; Anita Kramer; Anne M Lynch; Virginia D Winn
Journal:  Am J Reprod Immunol       Date:  2013-10-16       Impact factor: 3.886

Review 4.  Uterine disorders and pregnancy complications: insights from mouse models.

Authors:  Hyunjung Jade Lim; Haibin Wang
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

5.  Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.

Authors:  Anne M Lynch; Ronald S Gibbs; James R Murphy; Patricia C Giclas; Jane E Salmon; V Michael Holers
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

6.  Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.

Authors:  Tomoko Hayashi; Lucinda Beck; Cyprian Rossetto; Xing Gong; Osamu Takikawa; Kenji Takabayashi; David H Broide; Dennis A Carson; Eyal Raz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kusanovic Juan Pedro; Eleazar Soto; Francesca Gotsch; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

8.  Split immunological tolerance to trophoblast.

Authors:  Amanda de Mestre; Leela Noronha; Bettina Wagner; Douglas F Antczak
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.

Authors:  Anne M Lynch; Ronald S Gibbs; James R Murphy; Tim Byers; Margaret C Neville; Patricia C Giclas; Jane E Salmon; Trisha M Van Hecke; V Michael Holers
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

Review 10.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

Authors:  Seth L Masters; Anna Simon; Ivona Aksentijevich; Daniel L Kastner
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.